Guinea-Bissau vs Saudi Arabia: Prevalence of hypertension, male
Guinea-Bissau
36.0%
in 2019
Saudi Arabia
36.3%
in 2019
Guinea-Bissau rank
108th
Saudi Arabia rank
106th
Prevalence of hypertension, male over time
- Guinea-Bissau
- Saudi Arabia
How they compare
Saudi Arabia currently reports 36.3% against 36.0% in Guinea-Bissau, a difference of 0.3%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Guinea-Bissau ahead.
Guinea-Bissau ranks 108th and Saudi Arabia ranks 106th of 192 countries.
Guinea-Bissau has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37.4% | 34.8% | 2.5% | Guinea-Bissau |
| 2000s | 38.7% | 35.6% | 3.1% | Guinea-Bissau |
| 2010s | 37.4% | 36.0% | 1.4% | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, male, Guinea-Bissau or Saudi Arabia?
- Saudi Arabia, at 36.3% against 36.0% in Guinea-Bissau as of 2019.
- What is the difference in prevalence of hypertension, male between Guinea-Bissau and Saudi Arabia?
- 0.3%, with Saudi Arabia ahead.
- How many years of comparable data are there for Guinea-Bissau and Saudi Arabia?
- 30 years are reported by both, from 1990 to 2019.
- How do Guinea-Bissau and Saudi Arabia rank globally for prevalence of hypertension, male?
- Guinea-Bissau ranks 108th and Saudi Arabia ranks 106th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, male (% of male adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension, male, is the percentage of male adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.